Syndax Pharmaceuticals (SNDX) Assets (2015 - 2026)
Syndax Pharmaceuticals (SNDX) reported Assets of $703.65 million for Q2 2026, up 18.0% from $596.15 million a year earlier and up 48.9% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, Syndax Pharmaceuticals posted Assets of $529.71 million, down 26.9% from FY2024.
- Assets has a five-year compound annual growth rate of 12.0% (FY2020 to FY2025).
- By year, Assets came in at $724.82 million in FY2024 (+18.3%), $612.88 million in FY2023 (+23.3%), $497.24 million in FY2022 (+10.6%) and $449.66 million in FY2021 (+49.6%).
- The Q2 2026 figure ranks as the highest quarterly Assets since Q4 2024.
- Year over year, Assets gained in six of the last eight quarters, with growth averaging 7.8%.
- The high point for year-over-year Assets in five years was Q2 2022 (growth of 54.5%); the low point was Q4 2025 (a decline of 26.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $472.67 million (Q1 2026), $529.71 million (Q4 2025) and $551.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Syndax Pharmaceuticals | 1.59 Bn | -137.74 Mn | 69.58 Mn | 703.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 703.65 Mn |
| Mar 31, 2026 | 472.67 Mn |
| Dec 31, 2025 | 529.71 Mn |
| Sep 30, 2025 | 551.79 Mn |
| Jun 30, 2025 | 596.15 Mn |
| Mar 31, 2025 | 640.71 Mn |
| Dec 31, 2024 | 724.82 Mn |
| Sep 30, 2024 | 425.81 Mn |
| Jun 30, 2024 | 476.95 Mn |
| Mar 31, 2024 | 543.03 Mn |
| Dec 31, 2023 | 612.88 Mn |
| Sep 30, 2023 | 399.22 Mn |
| Jun 30, 2023 | 431.34 Mn |
| Mar 31, 2023 | 459.83 Mn |
| Dec 31, 2022 | 497.24 Mn |
| Sep 30, 2022 | 359.69 Mn |
| Jun 30, 2022 | 406.44 Mn |
| Mar 31, 2022 | 422.22 Mn |
| Dec 31, 2021 | 449.66 Mn |
| Sep 30, 2021 | 239.50 Mn |
API Access
Syndax Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();